Graham was pleased to present an update on UK market access at the EUCOPE meeting on 12th June in Belgium.
Graham was pleased to present an update on UK market access at the EUCOPE meeting on 12th June in Belgium.
Given the overlap in Joint Clinical Assessment (JCA) and national-level HTA timelines, manufacturers...
Read moreIntroduction Announced in the 2025 NHS 10-year plan, the National HealthTech Access Programme (NHAP)...
Read moreBe the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.
Get in touch